Randomized, controlled, multi‐center phase II study of postoperative enoxaparin treatment for venous thromboembolism prophylaxis in patients undergoing surgery for hepatobiliary‐pancreatic malignancies

Documenti analoghi

• Apparent diffusion coefficient in intrahepatic cholangiocarcinoma diffusion‐weighted magnetic resonance imaging noninvasively predicts Ki‐67 expression
  di: Daiki Hokkoku, et al.
  Pubblicazione: (2024)
• KLK10 derived from tumor endothelial cells accelerates colon cancer cell proliferation and hematogenous liver metastasis formation
  di: Kazuya Kato, et al.
  Pubblicazione: (2024)
• Exploratory prospective, randomized phase II study of neoadjuvant transcatheter arterial chemoembolization plus surgery versus surgery alone for large hepatocellular carcinoma (CSGO‐HBP‐005): Clinical Study Group of Osaka University, Hepato‐Biliary‐Pancreatic Group
  di: Shogo Kobayashi, et al.
  Pubblicazione: (2024)
• Value of venous thromboembolism prophylaxis by enoxaparin with anti-factor Xa trough concentration monitoring in surgical care
  di: Seeba Zachariah
  Pubblicazione: (2020)
• Discrepancy Between Radiographic and Pathological Response Assessment in Neoadjuvant Treatment for Pancreatic Cancer: A Comparison Between Neoadjuvant Chemotherapy and Neoadjuvant Chemoradiotherapy
  di: Satoru Miyahara, et al.
  Pubblicazione: (2025)